- Home
- VRA vs ANVS Comparison
VRA vs ANVS Comparison
Compare VRA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRA | ANVS |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 111.3M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VRA | ANVS |
|---|---|---|
| Price | $1.80 | $3.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.00 | ★ $13.50 |
| AVG Volume (30 Days) | 2.2M | ★ 4.0M |
| Earning Date | 12-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $324,296,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $1.11 |
| 52 Week High | $4.99 | $6.37 |
Technical Indicators
Market Signals| Indicator | VRA | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 33.72 | 51.96 |
| Support Level | $2.02 | $4.12 |
| Resistance Level | $2.26 | $4.64 |
| Average True Range (ATR) | 0.21 | 0.53 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 24.71 | 18.03 |
Price Performance
Historical ComparisonAbout VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.